Xerox Holdings Co. (NYSE:XRX – Get Free Report) EVP Suzan Morno-Wade sold 5,980 shares of the stock in a transaction that occurred on Tuesday, July 18th. The shares were sold at an average price of $16.00, for a total value of $95,680.00. Following the transaction, the executive vice president now owns 55,449 shares of the […]
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Get Free Report) was the target of a large growth in short interest in June. As of June 30th, there was short interest totalling 14,460,000 shares, a growth of 38.0% from the June 15th total of 10,480,000 shares. Based on an average daily volume of 2,360,000 shares, the days-to-cover ratio […]
Xerox Holdings Co. (NYSE:XRX – Get Free Report) has earned a consensus rating of “Strong Sell” from the three ratings firms that are covering the company, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a sell rating. The average 1-year price objective among analysts that have updated their coverage on the […]
Shares of Recursion Pharmaceuticals, Inc. (RXRX) are trading down on Thursday morning after surging to a year-to-date high on yesterday after announcing a collaboration and $50 million investment by Nvidia as a private investment in public equity.
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Free Report) CEO Lonnel Coats acquired 10,000 shares of Lexicon Pharmaceuticals stock in a transaction that occurred on Thursday, June 29th. The shares were purchased at an average cost of $2.16 per share, with a total value of $21,600.00. Following the purchase, the chief executive officer now owns 814,359 shares […]